Dangerous Substances and Devices

Avandia

FDA safety reviewers are urging a recall of the drug Avandia® due to increased risk of heart attacks. A congressional hearing addressing the safety of Avandia® concluded by alleging that GlaxoSmithKline knew the drug may cause Heart Damage several years before a medical study documented the reports.

Submit an Avandia claim, or read more about Avandia....

Denture Cream

Use of denture creams like Poligrip and Fixodent have been found cause neurological disorders due to zinc poisoning. Those who used the product and are suffering from numbness, tingling, muscle weakness or other neurological issues should contact their doctor.

Submit a Denture Cream claim, or read more about Denture Cream....

Reglan

The FDA has warned that Reglan a drug used to treat gastroesophageal reflux disease (GERD) and gastroesophageal reflux (GER) and has been found to cause Tardive Dyskinesia a serious movement disorder.

Submit a Reglan claim, or read more about Reglan ....

Yaz and Yasmin

Yaz and Yasmin are fourth generation birth control pills manufactured by Bayer Healthcare. First approved by the FDA in 2001 (Yasmin) and 2006 (Yaz), there is now increasing concern about the safety of the drugs. The FDA has received reports of more than 50 deaths among Yaz and Yasmin users.

Submit a Yaz and Yasmin claim, or read more about Yaz and Yasmin....

Relevant Articles

Diabetes Drugs Under Scrutiny   May 17, 2007

Drugs used to treat diabetes are increasingly being prescribed to prevent the disease, but the strategy is being questioned by some. Writing in the latest issue of BMJ, three diabetes researchers argue that the drug Avandia and other diabetes drugs should not be used for disease prevention because the long-term benefits of such treatments are not known. Continue reading ⇒

Filed under:
Ketek antibiotic to carry black box warning, new use limitations by FDA   May 17, 2007

The FDA has strengthened its warnings on the controversial antibiotic Ketek and banned the drug's use for treatment of sinusitis and bronchitis. The new move follows a yearlong FDA investigation into the drug's side effects. The use of the drug will still be permitted for pneumonia. Continue reading ⇒

Reports State that Irritable Bowel Syndrome (IBS) Medication Zelnorm May Increase Risk of Heart Attack and Stroke   May 17, 2007

On March 30, 2007 the U.S. Food and Drug Administration (FDA) announced that Novartis Pharmaceuticals had agreed to the FDA’ request that they voluntarily discontinue marketing and sales of Zelnorm (tegaserod maleate). Continue reading ⇒

Filed under:
Pergolide (Permax) Withdrawn Over Heart Valvulopathies   May 17, 2007

The FDA today withdrew the Parkinson's disease drug pergolide -- a dopamine agonist sold as Permax and as a generic -- because of an increased risk of valvular heart disease. Continue reading ⇒

Filed under:
FDA Announces Voluntary Withdrawal of Pergolide Products   May 17, 2007

The U.S. Food and Drug Administration (FDA) today announced that manufacturers of pergolide drug products, which are used to treat Parkinson’s disease, will voluntarily remove these drugs from the market because of the risk of serious damage to patients’ heart valves.  Continue reading ⇒

Filed under:

Lawsuits of Interest

Accutane  (isotretinoin)
Advair  (Fluticasone/salmeterol)
Arthritis Drugs
Asbestos / Mesothelioma
Avandia  (Rosiglitazone)
Bextra  (Valdecoxib)
Celebrex  (Celecoxib)
Chantix  (Varenicline)
Denture Cream
Digitek  (Digoxin)
Fill out this form for a free evaluation:
Please type your name.
Please type your email address.
Please select the cause of your injury.
Enter any information that you would lke us to know.